Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Effects of Onabotulinum toxin type A in patients with Meige’s syndrome

Author:Duarte, Alexia   Coutinho, Léo   Branco Germiniani, Francisco Manoel   Ghizoni Teive, Helio Afonso   

Session Name:P12: Movement Disorders: Dystonia 2  

Topic:Movement Disorders  

Program Number:P12.003  

Author Institution:Universidade Federal do Paraná, Curitiba, Brazil  Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, Brazil  

Validation of a Neurofilament Light Chain Assay on a Clinical Autoanalyzer

Author:Collier, Bradley B.   Chenna, Ahmed   Brandon, Whitney C.   Chappell, Matthew R.   Winslow, John   Petropoulos, Christos J.   Valcour, Andre   Volpe, Joseph   Grant, Russell P.   

Session Name:P5: General Neurology: Clinical Practice 1  

Topic:General Neurology  

Program Number:P5.006  

Author Institution:LabCorp, Burlington, NC  LabCorp, Durham, NC  

Participants United Through Retention and Education (PURE) Program for Non-motor Symptoms of Parkinson's Disease

Author:Lee, Stephen   Dubreus, Stacey   Sauveur, Sherline   Branson, Chantale   

Session Name:P6: Movement Disorders: Parkinson's Disease Non-motor Symptoms 1  

Topic:Movement Disorders  

Program Number:P6.009  

Author Institution:Morehouse School of Medicine, Marietta, GA  Boston University, Boston, MA  Morehouse School of Medicine, ATLANTA, GA  

Associations of Serum Neurofilament Light Chain with Outcomes in Children with Autoimmune Encephalitis

Author:Da Silva, Susana   Yea, Carmen   Madani, Jihan   Wagner, Matt   Longoni, Giulia   Branson, Helen M.   Vidarsson, Logi   Ertl-Wagner, Birgit   Yeh, E. Ann   

Session Name:P4: Autoimmune Neurology: Autoimmune Encephalitis / Paraneoplastic / Stiff-Person Syndrome / Immunotherapy (IrAe)  

Topic:Autoimmune Neurology  

Program Number:P4.009  

Author Institution:Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada  The Hospital for Sick Children, TORONTO, ON, Canada  

Long-term Follow-up of Cipaglucosidase Alfa/Miglustat in Ambulatory Patients with Pompe Disease: An Open-label Phase I/II Study (ATB200-02)

Author:Mozaffar, Tahseen   Schoser, Benedikt   Kishnani, Priya   Bratkovic, Drago   Clemens, Paula R.   Goker-Alpan, Ozlem   Ming, Xue   Roberts, Mark   Sivakumar, Kumaraswamy   Van Der Ploeg, Ans   Goldman, Mitchell   Wright, Jacquelyn   Holdbrook, Fred   Jain, Vipul   Sitaraman, Sheela   Wasfi, Yasmine   Byrne, Barry   

Session Name:S48: Therapeutics for Muscle Disease  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S48.007  

Author Institution:University of California, Irvine, Irvine, CA  Friedrich-Baur-Institut, Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany  Duke University Medical Center, Durham, NC  PARC Research Clinic, Royal Adelaide Hospital, Adelaide, SA, Australia  Department of Neurology, University of Pittsburgh School of Medicine, Division Chief, Neurology, Medical Service Line, VA Pittsburgh Healthcare System, Pittsburgh, PA  Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA  Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ  Salford Royal NHS Foundation Trust, Salford, United Kingdom  Neuromuscular Clinic and Research Center, Phoenix, AZ  Erasmus MC University Medical Center, Rotterdam, Netherlands  Amicus Therapeutics, Inc., Philadelphia, PA  University of Florida, Gainesville, FL